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A 72-year-old man presented with painless frank haematuria. Investigations included intravenous urogram and abdominal/pelvic
CT which revealed a marked focal thickening of the wall of the inferior aspect of the left renal pelvis extending into the lower
pole calyx and into the pelviureteric junction resulting in left hydronephrosis. Urine cytology demonstrated clusters of malignant
keratinised squamous cells and schistosome ova. He underwent left laparoscopic radical nephroureterectomy and histology
revealed moderately diﬀerentiated keratinising squamous cell carcinoma in the renal pelvis.
1. Introduction
In countries with a high prevalence of Schistosoma haemato-
bium there is a strong association with urinary tract pathol-
ogy [1]. A recognised common association is squamous cell
carcinoma (SCC) of the urinary bladder [2]. Schistosomiasis
involving the ureter is also associated with SCC but this is less
common than bladder cancer [3].
In nonschistosomiasis endemic areas, SCC of the urothe-
lium is rare and typically occurs in association with
chronic inflammation associated with long-term indwelling
catheters, urinary tract calculi, bladder diverticula, and
chronic urinary tract infections. Only 5% of all urothelial
tumours present in the upper urinary tract (ureter/renal
pelvis). The Swedish Cancer Registry, Ho¨lmang et al. [4],
reports that 8% of upper urinary tract urothelial tumours are
SCC, similar to previous reports of an incidence of 6–15%.
SCC of the upper urinary tract is a rare occurrence, and
an association of SCC of the renal pelvis with schistosomiasis
has not been previously described. We present a case of SCC
of the renal pelvis which was diagnosed by urine cytology
with schistosome ova alongside malignant keratinised squa-
mous cells.
Key Messages. Squamous cell carcinoma of the renal pelvis is
a rare complication of Schistosoma infection. Urine cytology
is a valuable tool in the investigation of patients with
haematuria and is pivotal in the diagnosis of urogenital
schistosomiasis. Management depends on the extent of organ
involvement but in the absence of metastatic disease, usually
involving radical surgical resection with systemic treatment
for schistosomiasis.
2. Case History
A 72-year-old man presented with two episodes of painless
frank haematuria. Preceding lower urinary tract symptoms
only consisted of mild hesitancy and straining with a
moderate stream. There was no other significant urological
history. He had smoked previously for 40 years at three packs
a day. He was a submariner during the Second World War
and then spent 30 years allegedly travelling in South America.
Ultrasound was reported as normal besides a mildly
enlarged prostate. Flexible cystoscopy demonstrated a tri-
lobar obstructing prostate with normal bladder urothelium.
An abnormal intravenous urogram showed dilatation of the
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Figure 1: Intravenous urogram demonstrating dilatation of the left
PC system with blunting and fullness of the calyces. There is an
unusual crescentic shape enhancement seen inferiorly at the left
renal pelvis.
Figure 2: Computed tomography scan showingmarked focal thick-
ening of the wall of the inferior aspect of the left renal pelvis
extending into the lower pole calyx and into the pelviureteric
junction resulting in left hydronephrosis.
left pelvicalyceal system with blunting and fullness of the
calyces. There was an unusual crescentic shape enhancement
seen inferiorly at the left renal pelvis (Figure 1). A CT scan
showed marked focal thickening of the wall of the inferior
aspect of the left renal pelvis extending into the lower pole
calyx and into the pelviureteric junction resulting in left
hydronephrosis (Figure 2).
There was no growth on culturing mid-stream urine.
Urine cytology revealed clusters of malignant keratinised
squamous cells and schistosome ova (Figures 3(a) and 3(b)).
He was given praziquantel at 40mg/kg. He underwent
left laparoscopic radical nephroureterectomy without com-
plications. Histology showed a moderately diﬀerentiated
keratinising squamous cell carcinoma arising from the renal
pelvis from an area of squamous metaplasia and dysplasia.
The carcinoma replaced much of the lower pole of the
kidney (Figure 4). The tumour focally extended into hilar
and perinephric fat, with widespread lymphatic, venous, and
perineural invasion. The main renal vein was not infiltrated.
All 12 lymph nodes were negative for malignancy (pT4, N0,
M0).
The patient presented five months later with multiple
lung lesions. He declined chemotherapy and unfortunately
died 10 weeks later.
3. Discussion
Schistosomiasis is a parasitic infection that infects 250
million people worldwide. Ten species of schistosomes can
infect humans, including S. mansoni, S. hematobium, and S.
japonicum [5]. Urinary tract disease is a hallmark of infection
by S. hematobium due to adult schistosomes producing ova
in venules of the genitourinary tract. Although involvement
of urogenital organs diﬀers markedly, it appears to correlate
with the degree of venous circulation. Hence, the urinary
bladder, lower ends of ureter, and seminal vesicles are most
commonly aﬀected owing to a rich venous supply [6].
In the upper urinary tract, ova can be found in all layers
of the ureter and can lead to fibrosis and stricture formation
[7]. Ureteric obstruction is therefore the most common
complication of S. hematobium infection, particularly the
endopelvic part of the ureter. Whilst SCC of the bladder is
well described in the literature, SCC of the upper urinary
tract in association with S. hematobium infection is rarely
cited [3].
Squamous metaplasia is a precursor for malignant
change and associated with chronic inflammation of the
urothelium. Case reports of upper tract nonschistosomi-
asis SCC, not unsurprisingly, describe predisposing fac-
tors associated with chronic inflammation, in particular
nephrolithiasis [8]. Several mechanisms are proposed to
explain the association between urinary schistosomiasis and
SCC of the bladder. Fibrosis induced by eggs leads to
proliferation, hyperplasia, and metaplasia of the urothelium,
which are precursors of malignancy [9]. Adult schistosomes
and miracidia have also been shown to have raised beta glu-
curonidase levels and hence release potentially carcinogenic
amines into the urine [10].
In this case, diagnosis of urinary schistosomiasis is based
on the detection of S. haematobium ova in the urine. The
ova count can be used to assess the severity of infection, and
the viability of ova in any given sample has been assessed
using Congo Red [5]. Novel detection techniques from urine
using PCR from DNA specific fragments have also recently
been reported [11]. Cystoscopy is commonly used in the
evaluation of lower urinary tract lesions and diagnosis can
be confirmed by finding ova with a granulomatous reaction
at histology [5].
Praziquantel or metrifonates are systemic treatments of
choice in S. hematobium. Praziquantel induces tetanic paral-
ysis and decreases glucose absorption in the trematode by
interfering with ionic exchange. Metrifonate is an organo-
phosphate that also causes paralysis by irreversibly blocking
cholinesterase [4].
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Figure 3: Urine cytology specimen showing (a) clusters of keratinised malignant squamous cells and (b) Schistosoma egg, probably with a
terminally located spine.
Figure 4: Lower pole of the left kidney largely replaced by a white
friable tumour which appears to arise from the pelvicalyceal mucosa
at the hilum. The tumour focally extends into hilar and perinephric
fat.
Surgical management of upper tract SCC associated with
schistosomiasis should follow the same principles as for
any upper tract SCC. Radical nephroureterectomy is the
treatment of choice for patients without metastasis and there
appears to be only little benefit for neoadjuvant and adjuvant
radiotherapy/chemotherapy [2]. The majority of upper tract
SCCs are of an advanced stage at time of treatment (T3/T4)
and this contributes to the overall poor prognosis of upper
urinary tract SCC, with less than 10% survival after 5 years
[2].
In those patients at risk for upper tract SCC, a high index
of suspicion should be maintained to improve detection
of disease at an earlier stage. In a case series which
included nephrectomies performed for nonfunctioning kid-
neys secondary to staghorn calculus, the first indication of
malignancy was the incidental finding of SCC on histological
examination of the nephrectomy specimen [7]. This further
emphasises the role of urine cytology in detecting upper
tract SCC in those patients presenting with haematuria or
in a population at high risk of developing SCC (e.g., chronic
inflammation due to nephrolithiasis and recurrent urinary
tract infections).
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